lanreotide acetate - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
MYTOLAC lanreotide (as acetate) 120 mg solution for injection pre-filled syringe AUST R: 371879Active ingredients:
lanreotide acetate
Dosage form:
Injection, solution
Sponsor:
Amdipharm Mercury Australia Pty Ltd
Phone:
1800 627 680
|
From
19 Jun 2024
to
31 Dec 2024
|
Shortage status:
Current
Availability:
Limited Availability
Reason:
Transport / Logistic issues / Storage capacity issues
Management action:
An alternative generic product is available. Sponsor is closely controlling the supply
|
MYTOLAC lanreotide (as acetate) 90 mg solution for injection pre-filled syringe AUST R: 371880Active ingredients:
lanreotide acetate
Dosage form:
Injection, solution
Sponsor:
Amdipharm Mercury Australia Pty Ltd
Phone:
1800627680
|
From
12 Aug 2024
to
31 Dec 2024
|
Shortage status:
Current
Availability:
Unavailable
Reason:
Transport / Logistic issues / Storage capacity issues
Management action:
An alternative generic product is available. Sponsor is working to expedite the next shipment
|
MYTOLAC lanreotide (as acetate) 60 mg solution for injection pre-filled syringe AUST R: 371881Active ingredients:
lanreotide acetate
Dosage form:
Injection, solution
Sponsor:
Amdipharm Mercury Australia Pty Ltd
Phone:
1800 627 680
|
From
30 Nov 2024
to
15 Jan 2025
|
Shortage status:
Anticipated
Availability:
Available
Reason:
Transport / Logistic issues / Storage capacity issues
Management action:
An alternative generic product is available. Sponsor is working to expedite the next shipment.
|